glp-1 keto Could GLP1 medications help patients go keto? Keto vs. GLP1 experience :

Such effects are consistent with their established reduction in atherosclerotic cardiovascular events and may be particularly relevant in patients with obesity, insulin resistance, or HFpEF phenotypes, and taken together, these mechanistic differences provide a biologically plausible rationale for combination therapy: SGLT2 inhibitors primarily target HF-related hemodynamic and cardiorenal pathways, whereas GLP-1 receptor agonists may further improve metabolic and vascular risk

These are predominantly present in the first eight to twelve weeks and resolve for the majority of participants after the body has adjusted to the compounds effects on gastric motility

And the suitability each med offers to you may depend less on those small differences and more on your biochemistry

They can evaluate whether a dose adjustment is needed, address any side effects affecting your progress, or recommend tweaks to your routine

In trials where semaglutide was added on to basal insulin with or without metformin, severe hypoglycemia (requiring the assistance of another person) was reported in 1.5% of semaglutide-treated patients